Pure Global

Efficacy and safety of high dose catechin-contained green tea in patients with NAFLD - Trial UMIN000018361

Access comprehensive clinical trial information for UMIN000018361 through Pure Global AI's free database. This phase not specified trial is sponsored by Kanazawa University Department of Disease Control and Homeostasis and is currently Recruiting. The study focuses on Nonalcoholic fatty liver disease (NAFLD).

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000018361
Recruiting
dietary supplement
Trial Details
University Hospital Medical Information Network โ€ข UMIN000018361
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Efficacy and safety of high dose catechin-contained green tea in patients with NAFLD

Study Focus

Interventional

dietary supplement

Sponsor & Location

Kanazawa University Department of Disease Control and Homeostasis

Japan

Timeline & Enrollment

N/A

Jul 21, 2015

N/A

ICD-10 Classifications

Liver disease, unspecified
Inflammatory liver disease, unspecified
Alcoholic liver disease, unspecified
Alcoholic fatty liver
Toxic liver disease, unspecified

Data Source

University Hospital Medical Information Network

UMIN000018361

Non-Device Trial